COVID-19 in Chronic Granulomatosis Disease: A Case Report.

Iran J Allergy Asthma Immunol

Department of Allergy and Clinical Immunology, Namazi Hospital, Shiraz University of Medical Sciences, Shiraz, Iran.

Published: August 2022

A novel coronavirus disease known as Coronavirus Disease 2019 (COVID-19) has spread quickly throughout the world, and it was declared a pandemic in March 2022. Chronic granulomatous disease (CGD) is a diverse group of genetic disorders characterized by recurrent bacterial and fungal infections, resulting in granulomas due to the inability of phagocytes to destroy microbes. Even though it is thought that impaired neutrophil activity is a protective mechanism against severe COVID-19-induced cytokine storms and hyper-inflammatory responses, patients with CGD have normal immunity to most viruses. Here, we present two CGD patients who were hospitalized due to severe COVID-19 infections, which suggests that COVID-19 might have a different pathogenesis than other viruses.

Download full-text PDF

Source
http://dx.doi.org/10.18502/ijaai.v21i4.10295DOI Listing

Publication Analysis

Top Keywords

coronavirus disease
8
covid-19
4
covid-19 chronic
4
chronic granulomatosis
4
disease
4
granulomatosis disease
4
disease case
4
case report
4
report novel
4
novel coronavirus
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!